AT6-33567-19473
2 vaccinations
2 coded responses
11 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 152 / PA
- Registered
- 2021-02-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-20
Registered in v-safe
-
2021-02-20
Dose 1 — Moderna
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-25
-
2021-03-20
Dose 2 — Moderna
-
2021-03-21
Survey response — days 1–6 daily, dose 2MedDRA: Insomnia, Rhinorrhoea — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Runny nose, sleeplessnessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-22
- 2021-03-23
- 2021-09-18
-
2022-03-22
Survey response — 12 months, dose 2MedDRA: Dizziness — Feeling: Good · Be unable to do your normal daily activitiesFree text: Randomly lightheaded and dizzyMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-20 | Moderna | |
| 2 | 2021-03-20 | Moderna |
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Runny nose, sleeplessness
Release 11 — 12 months, dose 2
Symptoms: Randomly lightheaded and dizzy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness | · | · | ✓ |
| SRO | Insomnia | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release